In this issue:
Light alcohol consumption can increase cancer risk
Final 10-year safety, efficacy data from BIG 2–98
Clinical outcomes in PALB2- mutated breast cancer
Efficacy of adjuvant trastuzumab in small HER2+ tumours
Palbociclib improves PFS in HR+ advanced breast cancer
Internal mammary RT improves survival in early breast cancer
Less than the standard of care = worse outcomes in the elderly
Breast cancer mortality after DCIS diagnosis
Aromatase inhibitors vs tamoxifen in early breast cancer
Adjuvant bisphosphonates in early breast cancer
Please login below to download this issue (PDF)